Table 1. Pretransplantation Clinical Profile of the Patients in the Study and Control Group.
| FK 506 | CyA | |
|---|---|---|
| Number | 59 | 50 |
| Median age | 2.7 years (0.2 to 16.5) | 1.8 years (0.3 to 15.2) |
| Male/female | 31/28 | 22/28 |
| Cholestatic liver disease | 38 | 36 |
| A-1-A | 3 | 3 |
| Neonatal hepatitis | 5 | 2 |
| Cystic fibrosis | 3 | 2 |
| Fulminant hepatitis | 2 | 2 |
| Hepatoblastoma | 2 | 2 |
| All others | 6 | 2 |
| Previous Kasai | 30 | 28 |
| PRA > 10% | 4 | 4 |
| Gross × (+) | ||
| Strongly | 1 | 4 |
| Weakly | 10 | 4 |